All news from Hematology & Oncology

Designer Immune Cells To Treat Leukemia

Chimeric antigen receptor T-cell therapy has produced some dramatic responses in pediatric acute lymphoblastic leukemia, but the responses have been less spectacular in other hematologic malignancies, and they have been disappointing in solid tumors.